TipRanks
Go Ultimate55% OFF

Christie (CTG) AI Stock Analysis

Top Page

GB:CTG

Christie

(LSE:CTG)

Select Model
Rating:70Outperform
Price Target:GBX 197.00â–²(27.10% Upside)
Action:reiterated
Date:08/06/26

The score is driven mainly by improving financial performance, especially stronger revenue, earnings, and cash flow recovery. Technicals are supportive and valuation is reasonable, while elevated leverage keeps the overall score below the highest tier.

Positive Factors
Revenue and profit recoveryRevenue increased 15.4% in 2024 and 18.0% in 2025, while net income rose from 0.5m to 3.4m. This rebound indicates stronger operating momentum and gives Christie a firmer earnings base to support investment and reinforce its specialist market position over the next several quarters.
Negative Factors
High leverageDebt exceeded equity at approximately 1.7x in 2024 and 3.1x in 2023, while equity remained small relative to assets. This capital structure limits financial flexibility, increases sensitivity to earnings setbacks, and may constrain Christie’s ability to fund expansion or absorb prolonged weakness.

Christie (CTG) vs. iShares MSCI United Kingdom ETF (EWC)

-20%0%20%40%60%80%100%GB:CTG+55.22%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
GBP 39.72M
Dividend Yield
2.58%
Average Volume (3M)
17.43K
Price to Earnings (P/E)
11.0
Beta (1Y)
0.20
Revenue Growth
19.99%
EPS Growth
79.90%
Country
UK
Employees
651
Sector
Industrials
Sector Strength
63
Industry
Specialty Business Services

Christie Business Overview & Revenue Model

Company Description

Christie Group plc is a well-established provider of professional services, operating across Europe and internationally. The company serves a diverse range of industries including hospitality, leisure, healthcare, medical, childcare, education, and r...

Christie Financial Statement Overview

Summary

Recent fundamentals are improving: revenue grew 18% in 2025, net income rose sharply, and operating/free cash flow strengthened. Balance sheet risk remains a drag because leverage is still elevated despite deleveraging progress and improved equity.

Income Statement

72Positive

Balance Sheet

58Neutral

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue71.81M70.60M60.39M52.34M69.19M61.25M
Gross Profit7.93M70.60M2.00M14.77M5.22M2.58M
EBITDA9.69M8.83M3.94M-1.25M7.25M6.94M
Net Income3.76M3.40M536.00K-3.80M3.21M3.58M
Balance Sheet
Total Assets32.89M34.38M29.51M29.45M36.44M36.94M
Cash, Cash Equivalents and Short-Term Investments8.70M9.40M4.87M1.34M8.84M8.17M
Total Debt8.93M9.48M8.71M10.34M11.65M12.23M
Total Liabilities26.80M29.02M24.40M26.15M28.04M35.38M
Stockholders Equity6.08M5.36M5.11M3.30M8.40M1.56M
Cash Flow
Free Cash Flow5.14M6.96M2.23M-4.38M4.39M1.80M
Operating Cash Flow5.60M7.47M2.73M-3.46M5.18M2.34M
Investing Cash Flow-280.00K-1.24M2.55M-797.00K-787.00K-487.00K
Financing Cash Flow-1.58M-1.70M-1.66M-3.32M-3.71M-3.21M

Christie Technical Analysis

Technical Analysis SentimentNegative
Last Price155.00

Price Trends

50DMA171.31Negative
100DMA156.93Negative
200DMA146.38Positive

Market Momentum

MACD-5.82Positive
RSI18.98Positive
STOCH25.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CTG, the sentiment is Negative. The current price of 155.00 is below the 20-day moving average (MA) of 167.44, below the 50-day MA of 171.31, and above the 200-day MA of 146.38, indicating a neutral trend. The MACD of -5.82 indicates Positive momentum. The RSI at 18.98 is Positive, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CTG.

Christie Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

GB:CTG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:ITRKGB:ITRK73OutperformGBP 9.10B28.5129.86%2.78%3.94%-8.14%
GB:CTGGB:CTG70OutperformGBP 39.47M10.9865.79%2.58%19.99%79.90%
GB:MTOGB:MTO67NeutralGBP 2.65B32.3515.86%2.15%10.55%-19.05%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
GB:SRPGB:SRP62NeutralGBP 2.75B18.7517.55%1.61%1.20%221.80%
GB:RTOGB:RTO54NeutralGBP 8.80B24.815.82%2.68%-0.18%39.04%

* Industrials Sector Average

Performance Comparison

-25%0%25%50%75%GB:CTGGB:ITRKGB:MTOGB:RTOGB:SRPDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:CTG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:CTGChristie Group plc155.0050.2748.00%
GB:ITRKIntertek Group plc5930.00988.4220.00%
GB:MTOMitie Group plc209.0050.4731.84%
GB:RTORentokil Initial350.10-61.73-14.99%
GB:SRPSerco Group plc288.2041.0916.63%

Christie Corporate Events

Business Operations and StrategyFinancial Disclosures

Christie & Co Sees Surge in UK Leisure Deals and Positive Sector Outlook

Positive
Oct 12, 2026

Christie Group’s agency and advisory arm, Christie & Co, has released its Leisure Market Review 2026, revealing a sharp rise in UK leisure sector deal activity and transaction efficiency. The firm advised on 125% more leisure business sales...

Business Operations and StrategyFinancial Disclosures

Christie Group Flags Surge in Pubs and Restaurants Deals and Values

Positive
Oct 6, 2026

Christie Group’s agency and advisory arm, Christie & Co, has released its 2026 Pubs & Restaurants Market Review, highlighting a marked rise in deal activity and transaction values across the sector despite ongoing cost pressures and shi...

Business Operations and StrategyFinancial Disclosures

Christie & Co’s 2026 Review Shows Strong UK Pharmacy Deal Activity and Rising Margins

Positive
Oct 1, 2026

Christie Group’s agency and advisory business Christie & Co has released its Pharmacy Market Review 2026, highlighting robust activity and improving financial performance in the UK pharmacy sector. The firm leverages its brokerage, valuatio...

Business Operations and StrategyDividendsFinancial DisclosuresM&A Transactions

Christie Group lifts interim dividend as profits and deal pipeline strengthen

Positive
Sep 28, 2026

Christie Group reported a 5.4% rise in first-half 2026 revenues to £36.0m, driven by growth across all five trading brands in both UK and international markets, with underlying operating profit up 11.1% and margins improving despite higher staff...

Business Operations and StrategyFinancial Disclosures

Christie & Co Report Points to Strong UK Care-Sector Deal Activity

Positive
Sep 24, 2026

Christie Group’s specialist agency and advisory arm, Christie & Co, has published its Care Market Review 2026, signalling a robust UK care sector after a record £12 billion of transactions in 2025 and strong ongoing interest from both...

Business Operations and StrategyProduct-Related Announcements

Christie Group launches revamped website to support growth and investor outreach

Positive
Sep 22, 2026

Christie Group plc, a London-listed provider of professional and financial services as well as stock and inventory systems to sectors including healthcare, hospitality and retail, has launched a new corporate website. The platform consolidates inform...

Business Operations and Strategy

Christie & Co report shows resilient demand in UK convenience and forecourt retail

Positive
Sep 16, 2026

Christie Group’s agency and advisory arm, Christie & Co, has published its Retail Market Review 2026, analysing transaction activity, buyer demand, trading conditions, regulation and emerging opportunities across UK convenience store and fo...

Business Operations and StrategyFinancial Disclosures

Christie Group sets date for interim results and investor presentation

Neutral
Sep 15, 2026

Christie Group plc will release its interim results for the six months ended 30 June 2026 on 28 September 2026, underscoring a key reporting milestone for the AIM-quoted business services provider. The announcement will give investors updated visibil...

Business Operations and Strategy

Christie Group Highlights Strengthening UK Dental Market in 2026 Review

Positive
Sep 8, 2026

Christie Group’s agency and advisory arm, Christie & Co, has released its Dental Market Review 2026, offering a detailed assessment of the UK dental sector based on transactional data, sentiment surveys and advisory work, alongside lending...

Business Operations and StrategyExecutive/Board Changes

Christie Group Adds Christie & Co Chief Darren Bond to Board

Positive
Sep 7, 2026

Christie Group plc has strengthened its board with the appointment of Darren Bond, Global Managing Director of Christie & Co, as an Executive Director with immediate effect. Bond brings extensive experience in valuation, brokerage, consultancy an...

Business Operations and Strategy

Christie & Co expands market-leading dental brokerage into Republic of Ireland

Positive
Aug 4, 2026

Christie Group’s agency and advisory arm, Christie & Co, has launched a dedicated dental brokerage service in the Republic of Ireland, extending its UK-leading dental advisory operation into a new European market. The move brings its specia...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 26, 2026